mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
0.002 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.002 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |